Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04777344 · ClinicalTrials.gov registry record · NA
Clinical Effort Against Smoke Exposure in Cystic Fibrosis
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT04777344 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 36 participants.
The verdict
NCT04777344, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The study will test the feasibility, acceptability, and preliminary efficacy of a multi-component smoking cessation intervention tailored to the needs of caregivers of children with CF and delivered in clinical settings as part of routine CF care. The ultimate goal of this effort is to reduce the exposure of children and adolescents with CF to tobacco smoke.
Interventions
- BEHAVIORAL Tobacco Treatment Specialist (TTS) intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2021-07-08 |
| Est. Completion | 2022-09-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04777344
The ClinicalTrials.gov registry entry for NCT04777344 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tobacco Treatment Specialist (TTS) intervention is the first listed.
NCT04777344 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04777344 about?
NCT04777344 is a clinical study titled "Clinical Effort Against Smoke Exposure in Cystic Fibrosis". The study will test the feasibility, acceptability, and preliminary efficacy of a multi-component smoking cessation intervention tailored to the needs of caregivers of children with CF and delivered in clinical settings as part of routine CF care. The ultimate goal of this effort is to reduce the ex...
What is the current status of trial NCT04777344?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2021-07-08. Estimated completion is 2022-09-27.
What interventions are being tested in trial NCT04777344?
The interventions under investigation include: Tobacco Treatment Specialist (TTS) intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04777344?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.